European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. IV. Assessment of skin thickening by modified Rodnan skin score.
作者信息
Valentini G, D'Angelo S, Della Rossa A, Bencivelli W, Bombardieri S
出版信息
Ann Rheum Dis. 2003 Sep;62(9):904-5. doi: 10.1136/ard.62.9.904.
Abstract
摘要
相似文献
1
European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. IV. Assessment of skin thickening by modified Rodnan skin score.欧洲硬皮病研究小组制定系统性硬化症的疾病活动标准。IV. 用改良Rodnan皮肤评分评估皮肤增厚情况。
Ann Rheum Dis. 2003 Sep;62(9):904-5. doi: 10.1136/ard.62.9.904.
2
Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II).改良 Rodnan 皮肤评分的最小临床重要差异：硬皮病肺研究（SLS-I 和 SLS-II）的结果。
Arthritis Res Ther. 2019 Jan 16;21(1):23. doi: 10.1186/s13075-019-1809-y.
3
The relationship between skin symptoms and the scleroderma modification of the health assessment questionnaire, the modified Rodnan skin score, and skin pathology in patients with systemic sclerosis.系统性硬化症患者皮肤症状与健康评估问卷的硬皮病修正版、改良罗德南皮肤评分及皮肤病理学之间的关系。
Rheumatology (Oxford). 2016 May;55(5):911-7. doi: 10.1093/rheumatology/kew003. Epub 2016 Feb 15.
4
Evaluation of skin thickness lesions in patients with Lyme disease measured by modified Rodnan total skin score.评价改良罗氏总皮肤评分法测量的莱姆病患者皮肤厚度病变。
Rheumatol Int. 2012 Oct;32(10):3189-91. doi: 10.1007/s00296-011-2157-7. Epub 2011 Sep 30.
5
Evaluation of Scleroderma Clinical Trials Consortium training recommendations on modified Rodnan skin score assessment in scleroderma.评估硬皮病临床试验联合会关于硬皮病改良 Rodnan 皮肤评分评估的培训建议。
Int J Rheum Dis. 2019 Jun;22(6):1036-1040. doi: 10.1111/1756-185X.13523. Epub 2019 Mar 6.
6
Improvement in skin thickening in systemic sclerosis associated with improved survival.系统性硬化症中皮肤增厚的改善与生存率提高相关。
Arthritis Rheum. 2001 Dec;44(12):2828-35. doi: 10.1002/1529-0131(200112)44:12<2828::aid-art470>3.0.co;2-u.
7
8
Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies.系统性硬化症的皮肤厚度评分：三项独立研究中观察者间变异性的评估
J Rheumatol. 1993 Nov;20(11):1892-6.
9
High-throughput quantitative histology in systemic sclerosis skin disease using computer vision.基于计算机视觉的系统性硬化症皮肤疾病高通量定量组织学。
Arthritis Res Ther. 2020 Mar 14;22(1):48. doi: 10.1186/s13075-020-2127-0.
10
Toll-like receptor 9 in systemic sclerosis patients: relation to modified Rodnan skin score, disease severity, and functional status.系统性硬皮病患者的 Toll 样受体 9：与改良 Rodnan 皮肤评分、疾病严重程度和功能状态的关系。
Clin Rheumatol. 2018 Mar;37(3):757-763. doi: 10.1007/s10067-017-3880-6. Epub 2017 Oct 26.
引用本文的文献
1
Kinesiophobia in Systemic Sclerosis: Relationship With Functional Status, Pulmonary Fibrosis, Depression, and Other Clinical Parameters.系统性硬化症中的运动恐惧：与功能状态、肺纤维化、抑郁及其他临床参数的关系
J Clin Med Res. 2025 May;17(5):256-261. doi: 10.14740/jocmr6202. Epub 2025 May 8.
2
Circulating extracellular vesicles as predictive biomarkers of progressive interstitial lung disease in systemic sclerosis-a prospective cohort study.循环细胞外囊泡作为系统性硬化症中进行性间质性肺疾病的预测生物标志物——一项前瞻性队列研究
Front Med (Lausanne). 2025 Apr 30;12:1594201. doi: 10.3389/fmed.2025.1594201. eCollection 2025.
3
Aberrant lipid profiles and lymphocyte counts in systemic sclerosis population, reassessing predictive value for concurrent cardiovascular diseases.系统性硬化症患者异常的血脂谱和淋巴细胞计数，重新评估并发心血管疾病的预测价值。
Front Immunol. 2025 Feb 19;16:1530909. doi: 10.3389/fimmu.2025.1530909. eCollection 2025.
4
Natural killer cells are decreased in systemic sclerosis and have diagnostic value for pulmonary arterial hypertension incorporation.自然杀伤细胞在系统性硬化症中减少，对合并肺动脉高压具有诊断价值。
Sci Rep. 2025 Feb 12;15(1):5178. doi: 10.1038/s41598-025-89238-z.
5
Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children.儿童治疗抵抗性自身免疫性疾病的自体造血干细胞移植（AHSCT）。
RMD Open. 2024 Jul 14;10(3):e004381. doi: 10.1136/rmdopen-2024-004381.
6
Patients with systemic sclerosis and low CD4 numbers after autologous stem cell transplantation have a favorable outcome.自体干细胞移植后 CD4 计数低的系统性硬化症患者预后良好。
Arthritis Res Ther. 2024 Mar 20;26(1):75. doi: 10.1186/s13075-024-03300-1.
7
Anti-carbamylated protein antibodies in systemic sclerosis.抗瓜氨酸化蛋白抗体在系统性硬化症中的作用。
Arthritis Res Ther. 2023 Jul 21;25(1):123. doi: 10.1186/s13075-023-03099-3.
8
Hands and feet radiologic involvements in systemic sclerosis.系统性硬化症的手足放射学表现
BMC Rheumatol. 2023 May 20;7(1):9. doi: 10.1186/s41927-023-00336-9.
9
Salivary Antioxidant Profile in Patients with Systemic Sclerosis and Periodontitis.系统性硬化症和牙周炎患者的唾液抗氧化谱。
Mediators Inflamm. 2023 Apr 24;2023:7886272. doi: 10.1155/2023/7886272. eCollection 2023.
10
Clinical and serological correlation of systemic sclerosis in Moroccan patients.摩洛哥患者系统性硬化症的临床与血清学相关性
Rheumatol Adv Pract. 2023 Apr 3;7(2):rkad036. doi: 10.1093/rap/rkad036. eCollection 2023.
Zotero 插件